Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

GRIN2A mutations cause epilepsy-aphasia spectrum disorders



Epilepsy-aphasia syndromes (EAS) are a group of rare, severe epileptic encephalopathies of unknown etiology with a characteristic electroencephalogram (EEG) pattern and developmental regression particularly affecting language. Rare pathogenic deletions that include GRIN2A have been implicated in neurodevelopmental disorders. We sought to delineate the pathogenic role of GRIN2A in 519 probands with epileptic encephalopathies with diverse epilepsy syndromes. We identified four probands with GRIN2A variants that segregated with the disorder in their families. Notably, all four families presented with EAS, accounting for 9% of epilepsy-aphasia cases. We did not detect pathogenic variants in GRIN2A in other epileptic encephalopathies (n = 475) nor in probands with benign childhood epilepsy with centrotemporal spikes (n = 81). We report the first monogenic cause, to our knowledge, for EAS. GRIN2A mutations are restricted to this group of cases, which has important ramifications for diagnostic testing and treatment and provides new insights into the pathogenesis of this debilitating group of conditions.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Figure 1: Phenotypes and segregation of GRIN2A mutations in four families with epilepsy-aphasia syndrome disorders.
Figure 2: The NR2A p.Thr531Met alteration increases the mean time of NMDA receptors in the open state.

Accession codes



NCBI Reference Sequence


  1. Berg, A.T. et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 51, 676–685 (2010).

    Article  Google Scholar 

  2. Tassinari, C.A. et al. Encephalopathy with electrical status epilepticus during slow sleep or ESES syndrome including the acquired aphasia. Clin. Neurophysiol. 111 (suppl. 2), S94–S102 (2000).

    Article  Google Scholar 

  3. Tsai, M.H. et al. Clinical genetic study of the epilepsy-aphasia spectrum. Epilepsia 54, 280–287 (2013).

    Article  Google Scholar 

  4. Deonna, T.W., Roulet, E., Fontan, D. & Marcoz, J.P. Speech and oromotor deficits of epileptic origin in benign partial epilepsy of childhood with rolandic spikes (BPERS). Relationship to the acquired aphasia-epilepsy syndrome. Neuropediatrics 24, 83–87 (1993).

    Article  CAS  Google Scholar 

  5. Scheffer, I.E. et al. Autosomal dominant rolandic epilepsy and speech dyspraxia: a new syndrome with anticipation. Ann. Neurol. 38, 633–642 (1995).

    Article  CAS  Google Scholar 

  6. Kugler, S.L. et al. An autosomal dominant genetically heterogeneous variant of rolandic epilepsy and speech disorder. Epilepsia 49, 1086–1090 (2008).

    Article  Google Scholar 

  7. Michelucci, R. et al. Familial epilepsy and developmental dysphasia: description of an Italian pedigree with autosomal dominant inheritance and screening of candidate loci. Epilepsy Res. 80, 9–17 (2008).

    Article  Google Scholar 

  8. Roll, P. et al. SRPX2 mutations in disorders of language cortex and cognition. Hum. Mol. Genet. 15, 1195–1207 (2006).

    Article  CAS  Google Scholar 

  9. Vears, D.F. et al. Clinical genetic studies in benign childhood epilepsy with centrotemporal spikes. Epilepsia 53, 319–324 (2012).

    Article  Google Scholar 

  10. Lesca, G. et al. Epileptic encephalopathies of the Landau-Kleffner and continuous spike and waves during slow-wave sleep types: genomic dissection makes the link with autism. Epilepsia 53, 1526–1538 (2012).

    Article  CAS  Google Scholar 

  11. Reutlinger, C. et al. Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region. Epilepsia 51, 1870–1873 (2010).

    Article  CAS  Google Scholar 

  12. Endele, S. et al. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat. Genet. 42, 1021–1026 (2010).

    Article  CAS  Google Scholar 

  13. de Ligt, J. et al. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367, 1921–1929 (2012).

    Article  CAS  Google Scholar 

  14. Carvill, G.L. et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat. Genet. 45, 825–830 (2013).

    Article  CAS  Google Scholar 

  15. O'Roak, B.J. et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338, 1619–1622 (2012).

    Article  CAS  Google Scholar 

  16. Talukder, I., Borker, P. & Wollmuth, L.P. Specific sites within the ligand-binding domain and ion channel linkers modulate NMDA receptor gating. J. Neurosci. 30, 11792–11804 (2010).

    Article  CAS  Google Scholar 

  17. Traynelis, S.F. et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol. Rev. 62, 405–496 (2010).

    Article  CAS  Google Scholar 

  18. Lesca, G. et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat. Genet. published online; doi:10.1038/ng.2726 (11 August 2013).

    Article  Google Scholar 

  19. O'Roak, B.J. et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246–250 (2012).

    Article  CAS  Google Scholar 

Download references


We thank the subjects and their families for participating in our research. H.C.M. is supported by a grant from the US National Institutes of Health (NIH; NINDS 1R01NS069605) and is a recipient of a Burroughs Wellcome Fund Career Award for Medical Scientists. This work was supported by the National Health and Medical Research Council of Australia (Program Grant 628952 to S.F.B. and I.E.S., Practitioner Fellowship 1006110 to I.E.S. and CJ Martin Fellowship (546493) to M.S.H.) and by a Health Research Council of New Zealand project grant to L.G.S. P.S. is supported by ANR (Agence Nationale de la Recherche) grant EPILAND with EuroBiomed label, and P.S., N. Burnashev and N. Bruneau are supported by INSERM.

Author information

Authors and Affiliations



G.L.C., H.C.M. and I.E.S. designed the study and wrote the manuscript. H.C.M. and I.E.S. supervised the study. G.L.C. constructed libraries, developed the variant calling pipeline (assisted by J.C.), analyzed sequence data, conducted RNA transcript analysis (assisted by E.G.) and performed haplotyping. J.C. and G.L.C. performed aCGH. A.K. performed mutation segregation analysis. B.J.O. and J.S. developed the MIP methodology and analysis pipeline. B.M.R., S.C.Y., L.G.S., S.J.T., M.-H.T. and R.W. performed phenotypic analysis. R.O., J.A.D. and M.S.H. conducted mutation screening in the BECTS cohort. B.M.R., S.F.B. and I.E.S. critically reviewed the manuscript. N.L., N. Bruneau, N. Burnashev and P.S. generated mutant transcripts and performed single-channel recordings and analysis.

Corresponding authors

Correspondence to Ingrid E Scheffer or Heather C Mefford.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1 and 2 and Supplementary Tables 1–3 (PDF 1954 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Carvill, G., Regan, B., Yendle, S. et al. GRIN2A mutations cause epilepsy-aphasia spectrum disorders. Nat Genet 45, 1073–1076 (2013).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing